Cargando…
Efficient disruption of bcr-abl gene by CRISPR RNA-guided FokI nucleases depresses the oncogenesis of chronic myeloid leukemia cells
BACKGROUND: The bcr-abl fusion gene encodes BCR-ABL oncoprotein and plays a crucial role in the leukemogenesis of chronic myeloid leukemia (CML). Current therapeutic methods have limited treatment effect on CML patients with drug resistance or disease relapse. Therefore, novel therapeutic strategy f...
Autores principales: | Luo, Zhenhong, Gao, Miao, Huang, Ningshu, Wang, Xin, Yang, Zesong, Yang, Hao, Huang, Zhenglan, Feng, Wenli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537404/ https://www.ncbi.nlm.nih.gov/pubmed/31138265 http://dx.doi.org/10.1186/s13046-019-1229-5 |
Ejemplares similares
-
Induction of apoptosis in imatinib sensitive and resistant chronic myeloid leukemia cells by efficient disruption of bcr-abl oncogene with zinc finger nucleases
por: Huang, Ningshu, et al.
Publicado: (2018) -
Intracellular delivery of anti-BCR/ABL antibody by PLGA nanoparticles suppresses the oncogenesis of chronic myeloid leukemia cells
por: Jiang, Guoyun, et al.
Publicado: (2021) -
Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing
por: Tsai, Shengdar Q., et al.
Publicado: (2014) -
CRISPR RNA-guided FokI nucleases repair a PAH variant in a phenylketonuria model
por: Pan, Yi, et al.
Publicado: (2016) -
TAL nucleases (TALNs): hybrid proteins composed of TAL effectors and FokI DNA-cleavage domain
por: Li, Ting, et al.
Publicado: (2011)